Category: Regulations
-
Report: Long, Complex Effort Needed to Stem Opioid Abuse
A report released today says years of coordinated public health efforts are needed at all levels to contain and reverse the current opioid abuse epidemic.
-
FDA Approves Sickle Cell Drug
The Food and Drug Administration today approved a new drug that reduces the tendency for blood cells in people with sickle cell disease to stick together and block blood vessels.
-
Device Shown to Reduce Migraine Occurrence
A clinical trial shows an electronic device worn with headphones reduces the number of days with migraines among people with a history of their occurrence.
-
Little Health Impact Found from Engineered Mosquitoes
An assessment by Dutch health authorities concludes mosquitoes genetically engineered to produce offspring that die before adulthood pose few health or environmental risks to humans.
-
Ransomware a Small Share of Malware Threats
Infographic: This chart shows number of new malware specimens, in millions, and the share of windows-based malware, in percent.
-
Nerve Stimulation Approved for Children’s Epilepsy
The U.S. Food and Drug Administration approved use of vagus nerve stimulation to treat epilepsy in children who do not respond to drug therapy as young as 4 years old.
-
Second Trial Approved for Cancer Pain Drug
The U.S. Food and Drug Administration approved a new clinical trial to test the efficacy and safety of an experimental drug designed to relieve stubborn chronic pain associated with cancer.
-
Long-Acting Drug Blocks Opioid Effects, Withdrawal
Findings from a clinical trial show a formulation of the drug buprenorphine given once a week blocks effects of subsequent opioid exposure and withdrawal symptoms.
-
FDA Approves Skin Infection Drug
The U.S. Food and Drug Administration approved a new drug that treats serious bacterial skin infections, including those often resistant to current antibiotics.
-
FDA Developing Digital Device Certification Process
The U.S. Food and Drug Administration expects to unveil a new procedure for certifying digital medical devices that the agency says should speed their entry to the market.